39069622|t|The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy.
39069622|a|BACKGROUND: Cerebral amyloid angiopathy (CAA) is characterized by amyloid-beta (Abeta) deposition in cerebral vessels, leading to lobar cerebral microbleeds (CMB) and intracerebral hemorrhages (ICH). Apolipoprotein J (ApoJ) is a multifunctional chaperone related to Abeta aggregation and clearance. Our study investigated the vascular impact of chronic recombinant human Apolipoprotein J (rhApoJ) treatment in a transgenic mouse model of beta-amyloidosis with prominent CAA. METHODS: Twenty-month-old APP23 C57BL/6 mice received 25 doses of rhApoJ (1 mg/kg) (n = 9) or saline (n = 8) intraperitoneally for 13 weeks, while Wild-type (WT) mice received saline (n = 13). Postmortem brains underwent T2*-weighted magnetic resonance imaging (MRI) to detect hemorrhagic lesions. Abeta levels and distribution, cerebral fibrinogen leakage, brain smooth muscle actin (sma), and plasma matrix metalloproteinases and inflammatory markers were analyzed after treatments. Additionally, plasma samples from 22 patients with lobar ICH were examined to determine the clinical relevance of the preclinical findings. RESULTS: rhApoJ-treated APP23 presented fewer cortical CMBs (50-300 mum diameter) (p = 0.012) and cortical larger hemorrhages (> 300 mum) (p = 0.002) than saline-treated mice, independently of Abeta brain levels. MRI-detected hemorrhagic lesions correlated with fibrinogen cerebral extravasation (p = 0.011). Additionally, rhApoJ-treated mice presented higher number of sma-positive vessels than saline-treated mice (p = 0.038). In rhApoJ-treated mice, human ApoJ was detected in plasma and in occasional leptomeningeal vessels, but not in the parenchyma, suggesting that its mechanism of action operates through the periphery. The administration of rhApoJ induced an increase in plasma Groalpha (p = 0.035) and MIP-1alpha (p = 0.035) levels, while lower MMP-12 (p = 0.046) levels, compared to the saline-treated group. In acute lobar ICH patients, MMP-12 plasma levels correlated with larger hemorrhage volume (p = 0.040) and irregular ICH shape (p = 0.036). CONCLUSIONS: Chronic rhApoJ treatment in aged APP23 mice ameliorated CAA-related neurovascular damage by reducing the occurrence of CMB. We propose that rhApoJ may prevent blood-brain barrier (BBB) leakage and CMB appearance partly through circulating MMP-12 modulation.
39069622	28	33	human	Species	9606
39069622	34	50	apolipoprotein J	Gene	1191
39069622	77	97	cerebral microbleeds	Disease	MESH:D002547
39069622	114	119	mouse	Species	10090
39069622	131	158	cerebral amyloid angiopathy	Disease	MESH:D016657
39069622	172	199	Cerebral amyloid angiopathy	Disease	MESH:D016657
39069622	201	204	CAA	Disease	MESH:D016657
39069622	240	245	Abeta	Gene	11820
39069622	296	316	cerebral microbleeds	Disease	MESH:D002547
39069622	318	321	CMB	Disease	MESH:D002547
39069622	327	352	intracerebral hemorrhages	Disease	MESH:D002543
39069622	354	357	ICH	Disease	MESH:D002543
39069622	360	376	Apolipoprotein J	Gene	1191
39069622	378	382	ApoJ	Gene	1191
39069622	426	431	Abeta	Gene	11820
39069622	525	530	human	Species	9606
39069622	531	547	Apolipoprotein J	Gene	1191
39069622	583	588	mouse	Species	10090
39069622	598	614	beta-amyloidosis	Disease	MESH:D000686
39069622	630	633	CAA	Disease	MESH:D016657
39069622	667	674	C57BL/6	CellLine	CVCL:C0MU
39069622	675	679	mice	Species	10090
39069622	797	801	mice	Species	10090
39069622	912	931	hemorrhagic lesions	Disease	MESH:D006470
39069622	933	938	Abeta	Gene	11820
39069622	1067	1079	inflammatory	Disease	MESH:D007249
39069622	1157	1165	patients	Species	9606
39069622	1177	1180	ICH	Disease	MESH:D002543
39069622	1374	1385	hemorrhages	Disease	MESH:D006470
39069622	1430	1434	mice	Species	10090
39069622	1453	1458	Abeta	Gene	11820
39069622	1486	1505	hemorrhagic lesions	Disease	MESH:D006470
39069622	1598	1602	mice	Species	10090
39069622	1671	1675	mice	Species	10090
39069622	1707	1711	mice	Species	10090
39069622	1713	1718	human	Species	9606
39069622	1719	1723	ApoJ	Gene	1191
39069622	1972	1982	MIP-1alpha	Gene	20302
39069622	2015	2021	MMP-12	Gene	17381
39069622	2095	2098	ICH	Disease	MESH:D002543
39069622	2099	2107	patients	Species	9606
39069622	2109	2115	MMP-12	Gene	17381
39069622	2153	2163	hemorrhage	Disease	MESH:D006470
39069622	2197	2200	ICH	Disease	MESH:D002543
39069622	2272	2276	mice	Species	10090
39069622	2289	2292	CAA	Disease	MESH:D016657
39069622	2301	2321	neurovascular damage	Disease	MESH:D013901
39069622	2352	2355	CMB	Disease	MESH:D002547
39069622	2430	2433	CMB	Disease	MESH:D002547
39069622	2472	2478	MMP-12	Gene	17381
39069622	Association	MESH:D016657	11820
39069622	Association	11820	1191
39069622	Association	MESH:D002543	11820
39069622	Negative_Correlation	MESH:D002547	1191
39069622	Association	MESH:D016657	1191

